Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1651
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $19.4M | ﹤0.01% |
307,849
-399,107
| -56% | -$27.4M |
|
|
CSGS
1652
DELISTED
CSG Systems International
CSGS
| $19.4M | ﹤0.01% |
468,968
-57,607
| -11% | -$2.64M |
|
1653
Helmerich & Payne
HP
$3.45B
| $19.4M | ﹤0.01% |
993,423
-315,475
| -24% | -$6.15M |
|
|
MINI
1654
DELISTED
Mobile Mini Inc
MINI
| $19.4M | ﹤0.01% |
656,760
-77,709
| -11% | -$2.32M |
|
1655
Cabot Corp
CBT
$4.23B
| $19.3M | ﹤0.01% |
522,272
-25,250
| -5% | -$845K |
|
1656
LendingTree
TREE
$474M
| $19.3M | ﹤0.01% |
66,825
-3,471
| -5% | -$838K |
|
|
ARI
1657
Apollo Commercial Real Estate
ARI
$889M
| $19.3M | ﹤0.01% |
1,970,614
-10,303
| -0.5% | -$87.4K |
|
1658
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $19.3M | ﹤0.01% |
176,634
+152,105
| +620% | +$15.7M |
|
|
NAV
1659
DELISTED
Navistar International
NAV
| $19.3M | ﹤0.01% |
683,852
-8,501
| -1% | -$202K |
|
1660
John Wiley & Sons Class A
WLY
$2.78B
| $19.3M | ﹤0.01% |
494,354
-3,169
| -0.6% | -$121K |
|
1661
Kodiak Sciences
KOD
$2.68B
| $19.2M | ﹤0.01% |
355,399
+18,618
| +6% | +$1.05M |
|
1662
Patrick Industries
PATK
$2.88B
| $19.2M | ﹤0.01% |
470,219
+4,001
| +0.9% | +$121K |
|
1663
Allegiant Air
ALGT
$2.82B
| $19.2M | ﹤0.01% |
175,790
-7,322
| -4% | -$669K |
|
1664
Fresenius Medical Care
FMS
$12.9B
| $19.2M | ﹤0.01% |
442,945
-25,662
| -5% | -$1.01M |
|
1665
Nu Skin
NUS
$259M
| $19.1M | ﹤0.01% |
500,922
+12,556
| +3% | +$403K |
|
1666
Acco Brands
ACCO
$403M
| $19M | ﹤0.01% |
2,682,950
+491,178
| +22% | +$3.05M |
|
1667
Iovance Biotherapeutics
IOVA
$1.95B
| $19M | ﹤0.01% |
693,911
-783,629
| -53% | -$25.8M |
|
|
ODP
1668
DELISTED
ODP
ODP
| $19M | ﹤0.01% |
810,535
-359,546
| -31% | -$7.84M |
|
1669
Cimpress
CMPR
$2.49B
| $19M | ﹤0.01% |
248,928
-18,866
| -7% | -$1.34M |
|
|
PACW
1670
DELISTED
PacWest Bancorp
PACW
| $19M | ﹤0.01% |
962,626
-14,132
| -1% | -$262K |
|
1671
Park National Corp
PRK
$3.8B
| $18.9M | ﹤0.01% |
269,083
+11,407
| +4% | +$835K |
|
1672
Upbound Group
UPBD
$1.2B
| $18.9M | ﹤0.01% |
678,993
+10,354
| +2% | +$230K |
|
1673
U-Haul Holding Co
UHAL
$14.4B
| $18.9M | ﹤0.01% |
624,260
+7,660
| +1% | +$224K |
|
|
BBBY
1674
DELISTED
Bed Bath & Beyond Inc
BBBY
| $18.8M | ﹤0.01% |
1,777,377
-313,614
| -15% | -$2.16M |
|
1675
Telus
TU
$15B
| $18.8M | ﹤0.01% |
1,122,698
-74,634
| -6% | -$1.24M |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.